Dyspepsia is having any one of the following: disturbing postprandial fullness, early satiation, epigastric pain and/or burning felt predominantly in the upper abdomen.

It is considered a symptom complex rather than a specific diagnosis.

Acid suppression is the recommended initial therapy.


  • Refers to pain or discomfort centered in the upper abdomen
    • Discomfort refers to a subjective sensation that the patient does not interpret as pain which may be characterized by or associated with upper abdominal fullness, early satiety, bloating, belching, nausea and vomiting (N/V)
    • Centered refers to pain or discomfort in or around the midline
  • Dyspepsia is considered a symptom complex rather than a specific diagnosis

Signs and Symptoms

  • Ulcer-like
    • Recurrent epigastric pain or discomfort
  • Reflux-like
    • Acid regurgitation
    • Heartburn
  • Dysmotility-like
    • Bloating in upper abdomen not accompanied by visible distension
    • Early satiety
    • N/V
    • Postprandial fullness
    • Upper abdominal discomfort often aggravated by food
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 11 Jul 2017
Nonoperative management of uncomplicated appendicitis in children entails an increased likelihood of repeat emergency department visits and hospitalizations compared with appendectomy, a retrospective study has found. Furthermore, close to half of those who receive nonoperative care require subsequent surgical removal of the appendix within the first year.
22 Aug 2017
The efficacy of scheduled intravenous (IV) proton pump inhibitors (PPIs) are comparable to that of IV PPI drip for most outcomes in acute nonvariceal upper gastrointestinal bleeding (ANVGIB), a recent systematic review and meta-analysis has found. Moreover, oral PPIs are as effective as scheduled IV for length of stay (LOS) and total units of blood transfused (UBT) and superior to IV PPI drip for risk of surgery (ROS).
Pearl Toh, 10 Jul 2017
Elderly persons (≥75 years) on aspirin-based antiplatelet therapy without routine proton-pump inhibitor (PPI) use have a higher long-term risk of major bleeding, in particular upper gastrointestinal (GI) bleeding which is often more disabling or fatal than in younger persons, according to the OXVASC* study.
07 Apr 2017
Use of thiopurine for inflammatory bowel disease (IBD) during pregnancy appears to neither pose an increased risk of spontaneous abortions or adverse birth outcomes nor negatively affect health outcomes of infants 1 year after birth, a study suggests.